These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10922393)

  • 1. Absence of germline p16(INK4a) alterations in p53 wild type Li-Fraumeni syndrome families.
    Portwine C; Lees J; Verselis S; Li FP; Malkin D
    J Med Genet; 2000 Aug; 37(8):E13. PubMed ID: 10922393
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
    Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
    Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
    Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
    Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mutational spectra of gene p53 in different types of tumors].
    Glazko GV; Rogozin IB; Sozinov AA
    Tsitol Genet; 1999; 33(3):14-20. PubMed ID: 10474858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.
    Güran S; Tunca Y; Imirzalioğlu N
    Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
    Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen LA; Blomqvist C; Aittomäki K; Nevanlinna H
    Cancer Res; 2001 Aug; 61(15):5718-22. PubMed ID: 11479205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
    Evans DG; Birch JM; Thorneycroft M; McGown G; Lalloo F; Varley JM
    J Med Genet; 2002 Dec; 39(12):941-4. PubMed ID: 12471212
    [No Abstract]   [Full Text] [Related]  

  • 10. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.
    Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G
    Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome.
    Dockhorn-Dworniczak B; Wolff J; Poremba C; Schäfer KL; Ritter J; Gullotta F; Jürgens H; Böcker W
    Eur J Cancer; 1996 Jul; 32A(8):1359-65. PubMed ID: 8869100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of germline p53 mutation using the enzyme mismatch cleavage method.
    Giunta C; Youil R; Venter D; Chow CW; Somers G; Lafferty A; Kemper B; Cotton RG
    Diagn Mol Pathol; 1996 Dec; 5(4):265-70. PubMed ID: 8955618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
    Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
    Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
    Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
    MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK
    J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.